Ferric citrate has been approved to treat iron-deficiency anemia. The approval appears to be for adult patients, and may be specifically for those with chronic kidney disease (CKD), although the scope of the approval is not entirely clear. The treatment has shown efficacy in clinical trials and may have renoprotective effects, but the details of the approval and its indications vary across reports.